Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial.
- DOI
- 10.1200/jco-24-02076
- Published
- 2025 May 20
- Container
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/jco-24-02076,
title = {Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial.},
author = {Gautschi O and Park K and Solomon BJ and Tomasini P and Loong HH and De Braud F and Goto K and Peterson P and Barker S and Liming K and Oxnard GR and Frimodt-Moller B and Drilon A},
year = {2025},
journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
doi = {10.1200/jco-24-02076},
url = {https://doi.org/10.1200/jco-24-02076}
}RIS
TY - JOUR TI - Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial. AU - Gautschi O AU - Park K AU - Solomon BJ AU - Tomasini P AU - Loong HH AU - De Braud F AU - Goto K AU - Peterson P AU - Barker S AU - Liming K AU - Oxnard GR AU - Frimodt-Moller B AU - Drilon A PY - 2025 JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology DO - 10.1200/jco-24-02076 UR - https://doi.org/10.1200/jco-24-02076 ER -
APA
O, G., K, P., BJ, S., P, T., HH, L., F, D. B., K, G., P, P., S, B., K, L., GR, O., B, F., & A, D. (2025). Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-24-02076
Source records
- pubmed · retrieved 2026-09-26T06:07:51.919Z
- europe-pmc · retrieved 2026-09-26T06:07:51.946Z